Drug interactions between Aldactone and Teveten
Results for the following 2 drugs: |
|
|---|---|
| Aldactone (spironolactone) | |
| Teveten (eprosartan) | |
Interactions between your selected drugs
spironolactone ⇔ eprosartan
Applies to: Aldactone (spironolactone) and Teveten (eprosartan)
MONITOR CLOSELY: The concomitant use of potassium-sparing diuretics and angiotensin II receptor blockers (ARBs) may increase the risk of severe hyperkalemia. The mechanism is additive potassium-sparing effects. Both agents individually have been associated with hyperkalemia. Patients with diabetes, heart failure, dehydration, or renal insufficiency, or who are taking more than 25 mg/day of spironolactone may have a greater risk of developing severe hyperkalemia from this combination.
MANAGEMENT: Caution is advised if ARBs are used with potassium-sparing diuretics, particularly in patients with renal impairment, diabetes, old age, worsening heart failure, and/or a risk for dehydration. Serum potassium and renal function should be checked regularly, and potassium supplementation should generally be avoided unless it is closely monitored. Patients should be given dietary counseling and advised to seek medical attention if they experience symptoms of hyperkalemia such as weakness, irregular heartbeat, confusion, tingling of the extremities, or feelings of heaviness in the legs.
See also...
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2009 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
